NVAX Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: Positive sentiment around Novavax's low side-effect vaccine and potential FDA approvals could drive demand, boosting stock prices.




Bearish Case: Regulatory delays and competition from mRNA vaccines persist, coupled with high implied volatility signaling market caution.




Potential Outcomes: 60% FDA approval boosts shares; 25% competition stifles growth; 15% unforeseen events trigger volatility.




Trading Oracle: Sign Up to access trading oracle trade ideas.



January 05, 2025


Novavax Forecast

NVAX        Novavax











Correlated Assets

Assets that tend to move strongly with NVAX



BLBD Forecast + Options Trading Strategies   BLBD  Blue Bird (0.9)


ING Forecast + Options Trading Strategies   ING  ING Groep (0.78)


LLY Forecast + Options Trading Strategies   LLY  Lilly(Eli) (0.76)


AZN Forecast + Options Trading Strategies   AZN  Astrazeneca (0.72)


KO Forecast + Options Trading Strategies   KO  Coca-Cola (0.72)



Uncorrelated Assets

Assets with little price relationship to NVAX



GTLS Forecast + Options Trading Strategies   GTLS  Chart Industries (-0.01)


DNN Forecast + Options Trading Strategies   DNN  Denison Mines (0.01)


EH Forecast + Options Trading Strategies   EH  EHang Holdings Ltd - (-0.01)


SCHW Forecast + Options Trading Strategies   SCHW  Charles Schwab (0.01)


XOP Forecast + Options Trading Strategies   XOP  SPDR Oil & Gas Exploration and Production (0.02)



Anticorrelated Assets

Assets that tend to move strongly against NVAX



APLE Forecast + Options Trading Strategies   APLE  Apple Hospitality REIT (-0.73)


DV Forecast + Options Trading Strategies   DV  DoubleVerify (-0.75)


CRNC Forecast + Options Trading Strategies   CRNC  Cerence (-0.75)


FRSH Forecast + Options Trading Strategies   FRSH  Freshworks (-0.76)


PATH Forecast + Options Trading Strategies   PATH  UiPath (-0.76)









Become a more profitable investor with AI optimized trading strategies






×

Chat with NVAX


 Ask any question about NVAX!